Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Fludioxonil is employed as an agricultural fungicide to control plant-pathogenic fungi such as Botrytis cinerea. Cryptococcus neoformans is a basidiomycetous human fungal pathogen that causes fatal disease in immunocompromised hosts. This paper demonstrates that three different signalling cascades regulate sensitivity of C. neoformans to fludioxonil. Fludioxonil inhibited growth of the serotype A sequence reference strain H99 but not that of the sequenced serotype D strain JEC21. In the drug-sensitive wild-type strain, fludioxonil exposure activated the Hog1 osmosensing pathway, and hog1 Δ mutations conferred fludioxonil resistance. Fludioxonil treatment caused cell growth inhibition following cell swelling and cytokinesis defects in the sensitive wild-type but not in a hog1 Δ mutant strain, suggesting that Hog1 activation results in morphological cellular defects. Fludioxonil exerted a fungistatic effect on the wild-type strain H99, but exhibited fungicidal activity against calcineurin mutant strains, indicating that the calcineurin pathway contributes to drug resistance in this fungus. Combination of fludioxonil and the calcineurin inhibitor FK506 synergistically inhibited C. neoformans growth. mpk1 Δ MAPK mutant strains exhibited fludioxonil hypersensitivity, indicating that this pathway also contributes to drug resistance. These studies provide evidence that the broad-spectrum antifungal drug fludioxonil exerts its action via activation of the Hog1 MAPK pathway and provide insight into novel targets for synergistic antifungal drug combinations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516 · cited 4×
“The immunophilintargeting drugs, FK506 and cyclosporin A, which are inhibitors of calcineurin, exhibit antifungal activity against several human fungal pathogens, such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus (Cruz et al., 2001; High, 1994; Odom et al., 1997a).”
InfluentialSelf-citationCalcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342 · cited 4×
“neoformans strains were assessed in accordance with the National Committee for Clinical Laboratory Standards (NCCLS) criteria for antifungal drug activity as previously described (Cruz et al., 2002).”
InfluentialSelf-citationOnyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282
Self-citationKraus, P. R., Fox, D. S., Cox, G. M., & Heitman, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03508.x · Cited by 217 · cited 3×
“Furthermore, the calcineurin pathway is involved in mating and cell wall integrity of C. neoformans (Cruz et al., 2001; Kraus et al., 2003).”
Self-citationFox, D. S., Cruz, M. C., Sia, R. A. L., Ke, H., Cox, G. M., Cardenas, M. E., & Heitman, J. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02295.x · Cited by 175
Self-citationDel Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.739-746.2000 · Cited by 169 · cited 2×
“Combinations of a calcineurin inhibitor with an inhibitor of 1,3-b-glucan synthase or an inhibitor of ergosterol exhibit dramatic synergistic antifungal activity against these pathogens in vitro (Cruz et al., 2002; Del Poeta et al., 2000; Onyewu et al., 2003; Steinbach et al., 2004).”
Cruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150 · cited 2×
“The immunophilintargeting drugs, FK506 and cyclosporin A, which are inhibitors of calcineurin, exhibit antifungal activity against several human fungal pathogens, such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus (Cruz et al., 2001; High, 1994; Odom et al., 1997a).”
Self-citation
Cited by
Botrytis cinerea : the cause of grey mould disease
WILLIAMSON, B., TUDZYNSKI, B., TUDZYNSKI, P., & VAN KAN, J. A. L. (2007) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2007.00417.x · Cited by 1,729
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Sensing the environment: lessons from fungi
Bahn, Y.-S., Xue, C., Idnurm, A., Rutherford, J. C., Heitman, J., & Cardenas, M. E. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1578 · Cited by 420
Self-citationMitogen-Activated Protein Kinase Pathways and Fungal Pathogenesis
Zhao, X., Mehrabi, R., & Xu, J.-R. (2007) · Eukaryotic Cell · doi:10.1128/ec.00216-07 · Cited by 367
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
Han, Q., Wu, F., Wang, X., Qi, H., Shi, L., Ren, A., Liu, Q., Zhao, M., & Tang, C. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.12538 · Cited by 173
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
McCarthy, M. W., Kontoyiannis, D. P., Cornely, O. A., Perfect, J. R., & Walsh, T. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix130 · Cited by 169
“which overactivates the HOG pathway and confers lethal effects [87].”
BackgroundSystematic functional analysis of kinases in the fungal pathogen Cryptococcus neoformans
Lee, K.-T., So, Y.-S., Yang, D.-H., Jung, K.-W., Choi, J., Lee, D.-G., Kwon, H., Jang, J., Wang, L. L., Cha, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12766 · Cited by 163
Self-citationCalcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis
Chen, Y.-L., Brand, A., Morrison, E. L., Silao, F. G. S., Bigol, U. G., Malbas, F. F., Nett, J. E., Andes, D. R., Solis, N. V., Filler, S. G., et al. (2011) · Eukaryotic Cell · doi:10.1128/ec.00310-10 · Cited by 107
Self-citationChen, Y.-L., Konieczka, J. H., Springer, D. J., Bowen, S. E., Zhang, J., Silao, F. G. S., Bungay, A. A. C., Bigol, U. G., Nicolas, M. G., Abraham, S. N., et al. (2012) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.112.002279 · Cited by 97
Self-citationHayes, B. M. E., Anderson, M. A., Traven, A., van der Weerden, N. L., & Bleackley, M. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1573-8 · Cited by 93
“neoformans [102, 121] and with azole drugs against several Candida species [122].”
BackgroundInfluentialStress Signaling Pathways for the Pathogenicity of Cryptococcus
Bahn, Y.-S., & Jung, K.-W. (2013) · Eukaryotic Cell · doi:10.1128/ec.00218-13 · Cited by 84
Self-citationFan, W., Idnurm, A., Breger, J., Mylonakis, E., & Heitman, J. (2007) · Infection and Immunity · doi:10.1128/iai.01977-06 · Cited by 57
“We also treated the eca1 mutant with fludioxonil, an antifungal drug that causes osmotic stress by activating the Hog1 mitogen-activated protein kinase and inducing the intracellular accumulation of glycerol (32, 40, 54, 76).”
BackgroundSelf-citationMelanin in fungi: Advances in structure, biosynthesis, regulation, and metabolic engineering
Qin, Y., & Xia, Y. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02614-8 · Cited by 57
Pianalto, K. M., Billmyre, R. B., Telzrow, C. L., & Alspaugh, J. A. (2019) · Genetics · doi:10.1534/genetics.119.302290 · Cited by 41
Cervantes-Chávez, J. A., Ali, S., & Bakkeren, G. (2011) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-09-10-0202 · Cited by 32
Metadata
- Authors
- Kojima, K., Bahn, Y.-S., & Heitman, J.
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2006-03-01
- Volume
- 152
- Issue
- 3
- Pages
- 591-604
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2121226976
- Cited by
- 125
- References
- 8
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.